MRSA Case Study

Some germs that commonly live on the skin and in the nose are called staphylococcus or "staph" bacteria. Usually staph bacteria don't cause any harm. However, sometimes they get inside the body through a break in the skin and cause an infection. These infections are usually treated with antibiotics. When common antibiotics don't kill the staph bacteria, it means the bacteria have become resistant to those antibiotics. This type of staph is called MRSA (Methicillin-Resistant Staphylococcus Aureus).

Methicillin-resistant Staphylococcus aureus, or more commonly, MRSA, is an emerging infectious disease affecting many people worldwide. MRSA, in particular, is a very interesting disease because although many people can be carriers of it, it generally only affects those with a depressed immune system; this is why it is so prevalent in places like nursing homes and hospitals. It can be spread though surgeries, artificial joints, tubing, and skin-to-skin contact. Although there is not one specific treatment of this disease, there are ways to test what antibiotics work best and sometimes antibiotics aren’t even necessary.

Describe methicillin resistant Staphylococcus aureus (MRSA) and its implications for patients who are diagnosed with this.

Methicillin-resistant Staphylococcus aureus, or MRSA, is a bacterium that is resistant to many available high- level beta-lactam antibiotics, which include penicillins, “antistaphylococcal” penicillins and cephalosporins. Staphyloccoci are the most important bacteria that cause disease in humans. MRSA is sometimes branded as a nosocomial infection as it usually plagues patients that are receiving treatment in a hospital. The skin is the most common site of infection, where MRSA can cause cellulitis, folliculitis, or boils in the skin, but can also commonly be found in the nose, underarm, groin, upper respiratory tract, intestine, vagina and rectal areas of the body. MRSA infections occur with there is a break in the skin that allows the Methicillin resistant

MRSA stands for Methicillin-resistant Staphylococcus aureus (MRSA) and is a bacterial infection that is highly resistant to some antibiotics. In short, antibiotics have been used since the 40's to stop the growth of bacteria. However, the more antibiotics are used, the quicker the bacteria become resistant to it while each year more types of bacteria adapt and become resistant to antibiotics. With MRSA being so resistant to many of the antibiotics, classifying it as a “super-bug”, it makes treatment of skin infections and invasive internal infections much more complicated. This leads to many yearly deaths. In fact, MRSA statistics show that more people die each year from MRSA infections than the

Methicillin-resistant Staphylococcus aureus (MRSA) is a drug resistant pathogen abundant in healthcare settings and the second most common overall cause of healthcare associated infections (HAIs) reported to the National Healthcare Safety Network (NHSN) (Jernigan & Kallan, 2010). The prevalence of MRSA is a significant problem found amongst many Intensive Care Units (ICUs) in the United States (US); critically ill patients are at higher risk for hospital-acquired infections. Acquisition and infection of MRSA may significantly prolong duration of hospital stays, increase healthcare costs, and contribute to higher mortality rates. According to national data, MRSA accounts for nearly 70 percent of Staphylococcus aureus strains isolated from

Methicillin-resistant staphylococcus also referred to as MRSA is a type bacterium that becomes immune to many antibiotics used to treat even the most common infection. MRSA has become an issue in hospitals around the globe as it is known to constanly change over time. Methicillin-resistant staphylococcus (MRSA) usually occurs in day care home, hospitals and other related health care facilities. It was reported that in 2005 the majority of all infection related cases came from an antibiotic-resistant bacterium, resulting in a high rate of death (Tacconelli, et al 2007). In 1961 (Enright, et al 2002) methicillin-resistant staphylococcus (MRSA) was first discovered in the United Kingdom and later made its way to Asia and after to the United States.

Methicillin-resistant Staphylococcus aureus, or MRSA is a source of major concern for public health. MRSA is no longer a sole property of inpatients’ infections, but spreads quickly in the community, responsible for more deaths in the US than AIDS. It demonstrates increasing prevalence not only among people with weak immune systems, but also among those who we consider to be the healthiest.

MRSA which is short for Methicillin Resistant Staphylococcus Aureus is a staph or skin contamination that is resistant to a part of the most grounded anti-toxins. At the point when Methicillin Resistant Staphylococcus Auereus was initially found a few years prior when it spread in many healing centers and after that into the group, this contamination was known as one of the primary diseases to be resistant to the most effective anti-microbials. Staph contaminations have been referred to following the mid twentieth century as one of the deadliest infections. Staphylococcal contaminations are maladies brought about by various staphylococcal microscopic organisms. Twenty to thirty percent of all sound people get this contamination in the

The increasing incidences of MRSA in the hospitalized patients are becoming an alarming problem due to the poor surveillance screening for risk of infection. The literature and synthesis of the evidence largely recommends that the use of universal MRSA surveillance can increase the identification of MRSA infection or carriage. Likewise, evidence suggest that the use of universal surveillance combined with the implementation of isolation precautions and other infection control measures will result to improved patient outcome (Guleri et al., 2011).

The occurrence of hospital acquired infections has become a norm in the health care system. Patients’ experiences of being infected with MRSA at a hospital and subsequently isolated follows 6 patients in their experiences after becoming infected with methicillin- resistant staphylococcus aureus (MRSA) in an outbreak in Sweden. MRSA this is a staphylococcus bacteria that has become resistant to antibiotics such as penicillin, which was traditionally used to treat it (Vyas, 2015).

MRSA is no longer solely transmitted throughout the health care setting, it is within the community. The risk factors of MRSA within the health care setting is being hospitalized because patient are more vulnerable, having an invasive medical device implanted because it allows MRSA easier access into the body and staying in a long-term care facility because even carriers of MRSA may spread the disease(Methicillin Resistant Staphyloccus aureus (MRSA), 2016). The risk factors within the community is partaking in contact activities because of the skin to skin contact and the cuts and abrasion which MRSA can get into and living in a crowded area or unsanitary conditions because MRSA can easily be spread (Methicillin Resistant Staphyloccus aureus (MRSA),

CA-MRSA stands for community-associated methicillin-resistant Staphylococcus aureus. MRSA is caused by a type of Staphylococcus aureus bacteria that are no longer affected by common antibiotic medicines (drug resistant bacteria). Staphylococcus aureus, which is often called staph, is a bacterium that normally lives on the skin or in the nose of some people. Staph on the surface of the skin or in the nose does not cause problems. However, if the staph enters the body through a cut, wound, or break in the skin, an infection can happen.

“Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of preventable nosocomial infections and is endemic in hospitals worldwide” (Sadsad, Sintchenko, McDonnell, Gilbert, p.1, 2013). MRSA is a bacterial infection that is resistant to antibiotics that are usually used to treat staphylococcus infections. MRSA is mostly found on the skin, but can also be seen in wound or sputum. Nurses and other healthcare workers can help prevent the spread of MRSA by maintaining a good hand washing hygiene, putting patients in isolated rooms. However, patients with a history of MRSA should have an indicator on the door to inform staff of the infection. Nurses and other staff that will have physical contact with patients should be meticulous about using standard precautions, such as wearing protective equipment like gowns and gloves when handling patients with

MRSA is a type of staph bacteria, and stands for Methicillin-resistant Staphylococcus aureus. Many antibiotics that usually treat staph infections are not effective in treating MRSA, as MRSA is resistant to antibiotics. Beta-lactams are the class MRSA is resistant to, and includes: penicillin, methicillin, and amoxicillin, to name a few. MRSA is a gram-positive bacterium, and on a gram stain, MRSA looks like a group of grapes.